Search research articles
Contact Us
Filters
Showing results (261-270 of 706) with videos related to
Page
of 71
Sort By:
American Heart Journal
|
August 13, 2011
Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD)
Hector M Medina, Christopher P Cannon, Xin Zhao, et al.
Rheumatology (Oxford, England)
|
February 19, 2009
Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study)
Bernard Combe, Gary Swergold, James McLay, et al.
Chest
|
September 24, 2004
Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Venu Menon, Robert A Harrington, Judith S Hochman, et al.
European Journal of Heart Failure
|
April 22, 2009
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program
Henry Krum, Sean P Curtis, Amarjot Kaur, et al.
The American Journal of Cardiology
|
October 10, 2002
Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification
Benjamin M Scirica, Christopher P Cannon, Carolyn H McCabe, et al.
American Heart Journal
|
October 3, 2002
Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy
Brad G Angeja, James de Lemos, Sabina A Murphy, et al.
Journal of the American College of Cardiology
|
October 15, 2011
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?
Apurva A Motivala, Christopher P Cannon, Vankeepuram S Srinivas, et al.
The American Journal of Cardiology
|
November 30, 2004
Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction
Minang P Turakhia, Sabina A Murphy, Tina L Pinto, et al.
JAMA
|
November 26, 2009
Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes
Dharam J Kumbhani, Christopher P Cannon, Gregg C Fonarow, et al.
The American Journal of Cardiology
|
July 29, 2017
Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II)
Mahfouz El Shahawy, Christopher P Cannon, Dirk J Blom, et al.
Page
of 71
Search research articles
Search
Showing results (261-270 of 706) with videos related to
Sort By:
Page
of 71
American Heart Journal
|
August 13, 2011
Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD)
Hector M Medina, Christopher P Cannon, Xin Zhao, et al.
Rheumatology (Oxford, England)
|
February 19, 2009
Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study)
Bernard Combe, Gary Swergold, James McLay, et al.
Chest
|
September 24, 2004
Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Venu Menon, Robert A Harrington, Judith S Hochman, et al.
European Journal of Heart Failure
|
April 22, 2009
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program
Henry Krum, Sean P Curtis, Amarjot Kaur, et al.
The American Journal of Cardiology
|
October 10, 2002
Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification
Benjamin M Scirica, Christopher P Cannon, Carolyn H McCabe, et al.
American Heart Journal
|
October 3, 2002
Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy
Brad G Angeja, James de Lemos, Sabina A Murphy, et al.
Journal of the American College of Cardiology
|
October 15, 2011
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?
Apurva A Motivala, Christopher P Cannon, Vankeepuram S Srinivas, et al.
The American Journal of Cardiology
|
November 30, 2004
Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction
Minang P Turakhia, Sabina A Murphy, Tina L Pinto, et al.
JAMA
|
November 26, 2009
Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes
Dharam J Kumbhani, Christopher P Cannon, Gregg C Fonarow, et al.
The American Journal of Cardiology
|
July 29, 2017
Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II)
Mahfouz El Shahawy, Christopher P Cannon, Dirk J Blom, et al.
Page
of 71